Barry G. Arnason to Treatment Outcome
This is a "connection" page, showing publications Barry G. Arnason has written about Treatment Outcome.
Connection Strength
0.057
-
Etretinate augments interferon beta-1b effects on suppressor cells in multiple sclerosis. Arch Neurol. 2001 Jan; 58(1):87-90.
Score: 0.017
-
Interferon beta in multiple sclerosis. Neurology. 1993 Apr; 43(4):641-3.
Score: 0.010
-
Efficacy and safety of interferon beta-1b sc in older RRMS patients--a posthoc analysis of the BEYOND study. J Neurol. 2013 Jul; 260(7):1838-45.
Score: 0.010
-
Interferon ß-1b and glatiramer acetate effects on permanent black hole evolution. Neurology. 2011 Apr 05; 76(14):1222-8.
Score: 0.009
-
Tolerability and safety profile of 12- to 28-week treatment with interferon beta-1b 250 and 500 microg QOD in patients with relapsing-remitting multiple sclerosis: a multicenter, randomized, double-blind, parallel-group pilot study. Clin Ther. 2008 Jun; 30(6):1102-12.
Score: 0.007
-
Interferons in relapsing remitting multiple sclerosis. Lancet. 2003 May 24; 361(9371):1822; author reply 1823-4.
Score: 0.005